Medical device exec looking to fund or sell three health-care start-ups
Roy Chin, a former executive medical device executive based in Pleasanton, has launched three health-care start-ups of his own, he tells VentureWire (sub required).
The companies are Nanovasc, focusing on vascular regeneration; Nanonerve Inc., with a concentration on neural regeneration products; and Spine View Inc., which is developing percutaneous tools for spinal surgery to replace more invasive procedures. The companies are all formed from technology licenses secured from Stanford University and the University of California at Berkley, Chin told VentureWire.
Two of the companies have similar underlying technology. “Nanovasc is a nanotechnology company with a proprietary compound that can regenerate new blood vessels and has a biodegradable stent,” he said. “Nanonerve is similar to Nanovasc, but it’s for nerve regeneration. The third company, Spine View, is developing percutaneous tools for spinal surgery to replace more invasive procedures, Chin said.
From the tone of the story, he is apparently trying to sell these companies or get money from investors.
Next Story: Akamai scoops up Redswoosh, to maintain CDN lead
Previous Story: Sun buys mobile phone Java operating system co., SavaJe
About the Author, Matt Marshall
Matt launched VentureBeat in September of 2006, with the realization that no one else was covering the entrepreneurial and tech innovation scene with the velocity or depth that he was. Prior to founding VentureBeat, he covered venture capital for the San Jose Mercury News from 2001 to 2006. In 2002, Matt was awarded "Journalist of the Year" by the Northern California Society of Professional Journalists. Prior to working at the Merc, he was a correspondent for the Wall Street Journal in Bonn, Germany from 1995 to 1998, and a writer for the Washington Post in 1994. Matt holds a PhD in Government and an MA in German and European Studies from Georgetown University. In addition to VentureBeat, Matt is also the Executive Producer of DEMO, the leading launchpad event for emerging technologies.
